$GBCS
SELECTIS HEALTH, INC.

2024 Q3 Form 10-Q Financial Statement

#000149315224032893 Filed on August 16, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $10.02M $9.585M
YoY Change 10.73% 7.35%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $9.939M
YoY Change -1.3%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $409.5K
YoY Change -6.93%
% of Gross Profit
Operating Expenses $11.19M $10.35M
YoY Change -2.36% -1.55%
Operating Profit -$1.172M -$763.9K
YoY Change -51.45% -51.75%
Interest Expense -$585.7K
YoY Change -203.22%
% of Operating Profit
Other Income/Expense, Net -$435.4K $1.558M
YoY Change -387.67% -401.0%
Pretax Income $794.3K
YoY Change -137.83%
Income Tax
% Of Pretax Income
Net Earnings -$1.607M $794.3K
YoY Change -28.96% -137.81%
Net Earnings / Revenue -16.04% 8.29%
Basic Earnings Per Share -$0.52 $0.26
Diluted Earnings Per Share -$0.52 $0.26
COMMON SHARES
Basic Shares Outstanding 3.067M shares 3.067M shares
Diluted Shares Outstanding 3.067M shares 3.067M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.221M
YoY Change 411.2%
Cash & Equivalents $1.823M $3.221M
Short-Term Investments
Other Short-Term Assets $586.4K
YoY Change -91.59%
Inventory
Prepaid Expenses
Receivables $1.904M $2.188M
Other Receivables $0.00
Total Short-Term Assets $3.533M $5.995M
YoY Change -40.27% -41.02%
LONG-TERM ASSETS
Property, Plant & Equipment $28.48M $28.86M
YoY Change -16.84% -16.65%
Goodwill $1.077M $1.077M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $802.7K
YoY Change -25.67%
Total Long-Term Assets $30.40M $30.74M
YoY Change -16.55% -16.42%
TOTAL ASSETS
Total Short-Term Assets $3.533M $5.995M
Total Long-Term Assets $30.40M $30.74M
Total Assets $33.93M $36.73M
YoY Change -19.86% -21.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.722M
YoY Change 12.98%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $900.0K
YoY Change 500.0%
Long-Term Debt Due $12.76M $10.60M
YoY Change 26.01% -1.73%
Total Short-Term Liabilities $20.20M $18.26M
YoY Change 37.24% 8.1%
LONG-TERM LIABILITIES
Long-Term Debt $18.47M $21.60M
YoY Change -28.77% -17.33%
Other Long-Term Liabilities $85.15K
YoY Change -71.62%
Total Long-Term Liabilities $18.47M $21.60M
YoY Change -28.77% -17.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $20.20M $18.26M
Total Long-Term Liabilities $18.47M $21.60M
Total Liabilities $38.76M $39.95M
YoY Change -6.96% -9.36%
SHAREHOLDERS EQUITY
Retained Earnings -$19.62M -$18.00M
YoY Change 39.07% 52.1%
Common Stock $153.4K $153.4K
YoY Change 0.41% 0.41%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$4.834M -$3.219M
YoY Change
Total Liabilities & Shareholders Equity $33.93M $36.73M
YoY Change -19.86% -21.75%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$1.607M $794.3K
YoY Change -28.96% -137.81%
Depreciation, Depletion And Amortization $409.5K
YoY Change -6.93%
Cash From Operating Activities -$422.9K
YoY Change -522.92%
INVESTING ACTIVITIES
Capital Expenditures -$89.77K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $2.485M
YoY Change
Cash From Investing Activities $2.575M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -161.2K
YoY Change -72.68%
NET CHANGE
Cash From Operating Activities -422.9K
Cash From Investing Activities 2.575M
Cash From Financing Activities -161.2K
Net Change In Cash 1.990M
YoY Change -506.22%
FREE CASH FLOW
Cash From Operating Activities -$422.9K
Capital Expenditures -$89.77K
Free Cash Flow -$333.1K
YoY Change -433.15%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3220581 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1484599 usd
CY2023Q2 GBCS Income From Employee Retention Credits
IncomeFromEmployeeRetentionCredits
usd
GBCS Other Income From Partial Settlement Of Debt
OtherIncomeFromPartialSettlementOfDebt
usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
usd
GBCS Increase Decrease In Employee Retention Credit Receivables
IncreaseDecreaseInEmployeeRetentionCreditReceivables
usd
us-gaap Proceeds From Sale Of Buildings
ProceedsFromSaleOfBuildings
usd
us-gaap Proceeds From Issuance Of Other Long Term Debt
ProceedsFromIssuanceOfOtherLongTermDebt
usd
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
usd
GBCS Payoff Of Secured Fixed Rate Mortgage Loan
PayoffOfSecuredFixedRateMortgageLoan
usd
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2024Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
2112143 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2100768 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
2862243 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-2963795 usd
us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
15000 usd
us-gaap Net Income Loss
NetIncomeLoss
-240376 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-3219171 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
952835 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
952835 usd
us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
15000 usd
us-gaap Net Income Loss
NetIncomeLoss
1924408 usd
us-gaap Net Income Loss
NetIncomeLoss
1924408 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
2862243 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
2862243 usd
us-gaap Net Income Loss
NetIncomeLoss
-240376 usd
us-gaap Net Income Loss
NetIncomeLoss
1924408 usd
GBCS Other Income From Partial Settlement Of Debt
OtherIncomeFromPartialSettlementOfDebt
50000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
833129 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
877578 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
95882 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
291688 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
200236 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
898135 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
2112143 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
296773 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
568877 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-647416 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-443600 usd
GBCS Increase Decrease In Employee Retention Credit Receivables
IncreaseDecreaseInEmployeeRetentionCreditReceivables
6095157 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
676806 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2302267 usd
us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
22400 usd
us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
9000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-173423 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
32642 usd
us-gaap Proceeds From Sale Of Buildings
ProceedsFromSaleOfBuildings
2484800 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
26862 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
42515 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2457938 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-42515 usd
us-gaap Proceeds From Issuance Of Other Long Term Debt
ProceedsFromIssuanceOfOtherLongTermDebt
501006 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
250000 usd
us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
815927 usd
us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
1198609 usd
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
6900 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-565927 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-704503 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1718588 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-714376 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2304723 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2416600 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4023311 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1702224 usd
us-gaap Interest Paid Net
InterestPaidNet
1083056 usd
us-gaap Interest Paid Net
InterestPaidNet
275725 usd
CY2024Q2 us-gaap Cash
Cash
3220581 usd
CY2023Q2 us-gaap Cash
Cash
625598 usd
CY2024Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
802730 usd
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1076626 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4023311 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1702224 usd
GBCS Dividends Declared On Series D Preferred Stock
DividendsDeclaredOnSeriesDPreferredStock
15000 usd
GBCS Dividends Declared On Series D Preferred Stock
DividendsDeclaredOnSeriesDPreferredStock
15000 usd
GBCS Payoff Of Secured Fixed Rate Mortgage Loan
PayoffOfSecuredFixedRateMortgageLoan
3736029 usd
GBCS Financing Of Insurance Premiums
FinancingOfInsurancePremiums
58256 usd
GBCS Financing Of Insurance Premiums
FinancingOfInsurancePremiums
673935 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-173423 usd
CY2024Q2 GBCS Working Capital Deficit
WorkingCapitalDeficit
-12300000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
794344 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2100768 usd
us-gaap Net Income Loss
NetIncomeLoss
-240376 usd
us-gaap Net Income Loss
NetIncomeLoss
1924408 usd
CY2024Q2 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
7500 usd
CY2023Q2 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
7500 usd
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
15000 usd
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
15000 usd
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
786844 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2108268 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-255376 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1909408 usd
CY2024Q2 GBCS Net Income Loss Attributable To Diluted Gross
NetIncomeLossAttributableToDilutedGross
794344 usd
CY2023Q2 GBCS Net Income Loss Attributable To Diluted Gross
NetIncomeLossAttributableToDilutedGross
-2100768 usd
GBCS Net Income Loss Attributable To Diluted Gross
NetIncomeLossAttributableToDilutedGross
-240376 usd
GBCS Net Income Loss Attributable To Diluted Gross
NetIncomeLossAttributableToDilutedGross
1924408 usd
CY2024Q2 GBCS Preferred Stock Dividends And Other Adjustments Diluted
PreferredStockDividendsAndOtherAdjustmentsDiluted
7500 usd
CY2023Q2 GBCS Preferred Stock Dividends And Other Adjustments Diluted
PreferredStockDividendsAndOtherAdjustmentsDiluted
7500 usd
GBCS Preferred Stock Dividends And Other Adjustments Diluted
PreferredStockDividendsAndOtherAdjustmentsDiluted
15000 usd
GBCS Preferred Stock Dividends And Other Adjustments Diluted
PreferredStockDividendsAndOtherAdjustmentsDiluted
15000 usd
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
786844 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-2108268 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-255376 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
1909408 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3067059 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3054587 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3067059 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3054587 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3067059 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3054587 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3067059 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3054587 shares
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.26
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.69
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.63
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.69
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.63
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
42977849 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
49256168 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
12562205 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
13878450 usd
CY2024Q2 GBCS Impairment Property Plant And Equipment
ImpairmentPropertyPlantAndEquipment
1560000 usd
CY2023Q4 GBCS Impairment Property Plant And Equipment
ImpairmentPropertyPlantAndEquipment
1560000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28855644 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
33817718 usd
us-gaap Depreciation
Depreciation
833129 usd
us-gaap Depreciation
Depreciation
877578 usd
CY2024Q2 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
33556085 usd
CY2023Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
37801902 usd
CY2024Q2 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
459485 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
555367 usd
CY2024Q2 GBCS Debt Longterm And Shortterm Combined Net Amount
DebtLongtermAndShorttermCombinedNetAmount
33096600 usd
CY2023Q4 GBCS Debt Longterm And Shortterm Combined Net Amount
DebtLongtermAndShorttermCombinedNetAmount
37246535 usd
CY2024Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
10596535 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
11170100 usd
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
21600065 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
25176435 usd
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3067059 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3067059 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
30000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.00
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
30000 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.00

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001493152-24-032893-index-headers.html Edgar Link pending
0001493152-24-032893-index.html Edgar Link pending
0001493152-24-032893.txt Edgar Link pending
0001493152-24-032893-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
gbcs-20240630.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
gbcs-20240630_cal.xml Edgar Link unprocessable
gbcs-20240630_def.xml Edgar Link unprocessable
gbcs-20240630_lab.xml Edgar Link unprocessable
gbcs-20240630_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending